Artificial intelligence (AI) applications have become widely popular across the healthcare ecosystem. Colon capsule endoscopy (CCE) was adopted in the NHS England pilot project following the recent COVID pandemic’s impact. It demonstrated its capability to relieve the national backlog in endoscopy. As a result, AI-assisted colon capsule video analysis has become gastroenterology’s most active research area. However, with rapid AI advances, mastering these complex machine learning concepts remains challenging for healthcare professionals. This forms a barrier for clinicians to take on this new technology and embrace the new era of big data. This paper aims to bridge the knowledge gap between the current CCE system and the future, fully integrated AI system. The primary focus is on simplifying the technical terms and concepts in machine learning. This will hopefully address the general “fear of the unknown in AI” by helping healthcare professionals understand the basic principle of machine learning in capsule endoscopy and apply this knowledge in their future interactions and adaptation to AI technology. It also summarises the evidence of AI in CCE and its impact on diagnostic pathways. Finally, it discusses the unintended consequences of using AI, ethical challenges, potential flaws, and bias within clinical settings.

Lower gastrointestinal diagnostics have been facing significant capacity constraints, which the COVID-19 pandemic has exacerbated due to significant reductions in endoscopy procedures. Colon Capsule Endoscopy (CCE) provides a safe, viable solution to offset ongoing demand and could be a valuable tool for the recovery of endoscopy services post-COVID. NHS Scotland has already begun a country-wide rollout of CCE as a managed service, and NHS England have committed to a pilot scheme of 11,000 capsules via hospital-based delivery. Here, we outline a proven method of CCE delivery that ensures the CCE and results are delivered in an efficient, clinically robust manner with high patient acceptability levels through a managed service. Delivering CCE without a managed service is likely to be slower, more costly, and less effective, limiting the many benefits of CCE as an addition to the standard diagnostic pathway for bowel cancer.

Background: Colon capsule endoscopy (CCE) has seen increased adoption since the COVID-19 pandemic, offering a non-invasive alternative for lower gastrointestinal investigations. However, inadequate bowel preparation remains a key limitation, often leading to higher conversion rates to colonoscopy. Manual assessment of bowel cleanliness is inherently subjective and marked by high interobserver variability. Recent advances in artificial intelligence (AI) have enabled automated cleansing scores that not only standardise assessment and reduce variability but also align with the emerging semi-automated AI reading workflow, which highlights only clinically significant frames. As full video review becomes less routine, reliable, and consistent, cleansing evaluation is essential, positioning bowel preparation AI as a critical enabler of diagnostic accuracy and scalable CCE deployment. Objective: This CESCAIL sub-study aimed to (1) evaluate interobserver agreement in CCE bowel cleansing assessment using two established scoring systems, and (2) determine the impact of AI-assisted scoring, specifically a TransUNet-based segmentation model with a custom Patch Loss function, on both interobserver and intraobserver agreement compared to manual assessment. Methods: As part of the CESCAIL study, twenty-five CCE videos were randomly selected from 673 participants. Nine readers with varying CCE experience scored bowel cleanliness using the Leighton–Rex and CC-CLEAR scales. After a minimum 8-week washout, the same readers reassessed the videos using AI-assisted CC-CLEAR scores. Interobserver variability was evaluated using bootstrapped intraclass correlation coefficients (ICC) and Fleiss’ Kappa; intraobserver variability was assessed with weighted Cohen’s Kappa, paired t-tests, and Two One-Sided Tests (TOSTs). Results: Leighton–Rex showed poor to fair agreement (Fleiss = 0.14; ICC = 0.55), while CC-CLEAR demonstrated fair to excellent agreement (Fleiss = 0.27; ICC = 0.90). AI-assisted CC-CLEAR achieved only moderate agreement overall (Fleiss = 0.27; ICC = 0.69), with weaker performance among less experienced readers (Fleiss = 0.15; ICC = 0.56). Intraobserver agreement was excellent (ICC > 0.75) for experienced readers but variable in others (ICC 0.03–0.80). AI-assisted scores were significantly lower than manual reads by 1.46 points (p < 0.001), potentially increasing conversion to colonoscopy. Conclusions: AI-assisted scoring did not improve interobserver agreement and may even reduce consistency amongst less experienced readers. The maintained agreement observed in experienced readers highlights its current value in experienced hands only. Further refinement, including spatial analysis integration, is needed for robust overall AI implementation in CCE.